A Post Market Trial Assessing the Accuracy of Normal Mode Reading vs. ProScan Reading With the NaviCam SB System. This is a Comparison of Retrospectively Obtained Capsule Endoscopy Videos With a New AI Reading Tool; no New Interventions Will be Completed.

The clinician is responsible for conducting their own assessment of the findings of the AI-assisted reading through review of the entire video, as clinically appropriate. ProScan also assists small bowel endoscopy reviewers in identifying the digestive tract location (oral cavity and beyond, esophagus, stomach, small bowel) of the image in adults. The tool is not intended to replace clinical decision making.

Inclusion criteria

• Patients of all genders, races, ethnicities and geographical backgrounds, from 22 years of age or older.
• Patient agrees to sign informed consent and follow all study procedures.

Exclusion criteria

• In patients with known or suspected gastrointestinal obstruction, strictures, or fistulas based on the clinical picture or pre-procedure testing and profile.
• In patients with cardiac pacemakers or other implantable electronic medical devices (MR unsafe devices only).
• In patients with dysphagia with high risk of aspiration.
• In pregnant women.
• GI motility issues (gastroparesis)
• GI dysmotility
• Chronic opioid usage
• Requires endoscopic placement
• In patients with endoscopic biopsies within one week of scheduled capsule ingestion
• No NSAID use within 14 days of scheduled capsule ingestion
• No GLP-1 drugs within 7 days of scheduled capsule ingestion